ArticleNagoya journal of medical science2022

Tolerability of neoadjuvant chemotherapy for esophageal cancer in elderly patients over 76 years of age.

Takafumi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.